MedPath

Nutrient Levels Alter Transplant Outcome

Not Applicable
Completed
Conditions
Chronic Renal Disease
Registration Number
NCT00560014
Lead Sponsor
University of Cincinnati
Brief Summary

The purpose of this study is to look at lipid profiles of plasma and RBC and amino acid profiles in plasma to determine if they are associated with allograft rejection, calcineurin inhibitor toxicity or new onset diabetes mellitus in renal transplant patients receiving dietary supplements with arginine and omega-3 fatty acids.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
54
Inclusion Criteria
  • Renal transplant recipient
  • Appropriate blood samples drawn and analyzed
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Primary Outcome Measures
NameTimeMethod
Plasma and red blood cell lipid profilesWithin 1 year
Plasma amino acid profileswithin 1 year
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Washington Hospital

🇺🇸

Washington, District of Columbia, United States

Duke University School Of Medicine

🇺🇸

Durham, North Carolina, United States

Washington Hospital
🇺🇸Washington, District of Columbia, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.